版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、GENE THERAPY,By Sam Lai and Meng Lee,Gene Therapy,Introduction : What is it?Gene Therapy : A Closer LookHow much did you learn?!Case Study : SCIDModel for Gene Therapy Medical FrameworkDiscussion / Q&A,What is i
2、t?,Gene therapy, which was first conceived in the mid-1970s, aims to insert working copies of genes into cells containing dysfunctional ones treat, cure, or ultimately prevent disease by changing the expression of a per
3、son's genes current gene therapy is primarily experimental, with most human clinical trials only in the research stages Most often in context of treating lethal and disabling diseases, potential also for disease pr
4、evention,Human Genome Project,A genome is all the DNA in an organism, including its genes. Genes carry information for making all the proteins required by all organisms Variations in structure of person’s genes collecti
5、vely helps define us as individualsRationale for GT is based on knowledge of the human genetic code Began formally in 1990, set as a 13 year project.,HGP GOALS,Identify aproximately 30,000 genes Determine 3 billion ch
6、emical base pairs that make up human DNAStore information in databasesImprove tools for data analysisAddress ethical, legal and social issues that might arise from this,HGP cont…,Achieve these goals, researchers look
7、at genetic makeup of other organismsThis project is important because the government's dedication to the transfer of technology to the private sector,,Which Cells Targeted?,somatic gene therapy the recipient's g
8、enome is changed, but the change is not passed along to the next generation germline gene therapy, the sex cells are changed with the goal of passing these changes to their offspring. But, this is not being actively inv
9、estigated, at least not humans, although a lot of discussion is being conducted about its value and desirability.,Somatic Stem Cells,Somatic stem cells are remarkable cells in the bodyThese different stem cell types are
10、 targets for gene therapyGenetically treated stem cells, when reintroduced into the patient's body are expected to naturally travel through the blood stream to the bone marrow.,Germline Gene Therapy,Gene therapy in
11、germline cells has the potential to affect not only the individual, but also their children as well. Any genetic changes in the reproductive cells or changes made to the embryo before the stage of differentiation, would
12、 affect all future offspring of that person. This makes an vital distinction, affecting major ethcial issues,Delivery of Genes,Need an efficient method to deliver the gene to live cells.Done via vectors (gene carriers),
13、 delivering therapeutic genes to cells - common vector is virusesAlternative delivery methods seen with use of lipids and proteins,Use of Viruses,Viruses evolved a way of delivering their genes to human cells in path
14、ogenic matter.Take advantage of this, manipulate genome to remove disease genes and insert therapeutic genes,,Risks with GT trials,Viruses can usually infect more than one type of cell. When DNA is injected directly in
15、to a tumor, there is a slight chance that this DNA could unintentionally be introduced into reproductive cells.Other concerns include the possibility that transferred genes could be "overexpressed",,Add a new
16、chromosome?,Experimentation seen with introduction of 47th chromosome Exist along 46th chromosome, large vector capable carrying genetic code, that hopefully the immune system would not attack,Understanding?,Scientists
17、know little about function of the thousands of genes. Attempting therapy without this knowledge would address few genes of a particular diseasei.e. Sickle Cell Anemia,Sickle Cell Anemia,Caused by error in gene that inf
18、orms our body on how to make hemoglobinPrevalent in African AmericansHowever deadly the error is, this increased the survival rate for those who also had malaria in the region,Hurdles…,Most genetic disorders involve mo
19、re than one gene, only few genetic diseases involve merely oneThis multigene disorders also involve the environment, such as diet, exercise, smoking, etc.,,Everything has a price,High costs associated with developing th
20、is technology, and regulations that needed to be implied on it with experimentations are great hurdles for experimenters in this field.,First Human Gene Therapy attempt,Began in 1990, using ex vivo strategy, where patien
21、t cells were cultivated in laboratory and incubated with vectorstransplanted back into the patientAttempted to treat 2 genetic disorders, including children with immune defiency as well as people with high levels of se
22、rum cholesterol,First Human GT cont…,Practical approaches, delivering genes based on so-called in vivo GT where viruses are directly given to patientsFirst model was dependent on a version of adenovirus to treat cystic
23、fibrosis,GT on Cancer Treatment,Researchers are working to improve the body's natural ability to fight the disease or to make the cancer cells more sensitive to other kinds of treatment, such as chemotherapy Substit
24、ution of a "working" copy of a gene for an inactive or defective gene.,GT on Cancer cont…,Injection of cancer cells with a gene that makes them more sensitive to treatment with an anticancer drug. Introduction
25、 of the multidrug resistance gene into stem cells. The MDR gene is used to make the stem cells more resistant to the side effects of the high doses of anticancer drugs.,Hurdles Summary,There are many obstacles that preve
26、nt researchers and scientist from developing successful gene therapy techniques.The issues being confronted are the same ones that are faced whenever a powerful new technology is developed.,When All is Said…,A proposed
27、gene therapy trial, or protocol, must be approved by at least two review boards at the scientists' institution. Any studies involving humans must be reviewed with great care.,CASE STUDY: SCID,SCID = Severe Combined
28、Immunodeficiency,What is SCID?,SCID patients can neitherConstruct cell-mediated immune responseMake AntibodiesPatients do not die of SCID itselfMore Boys than Girls,SCID Cases, Past & Present,Not discovered until
29、 early 1960sOccur in 1 out of 1.000,000“Bubble Boy” – David VetterSpent 12 years in Texas Hospital Sterile TentUsually not discovered until too late,Science Behind SCID (1),What Happens in SCIDLymphocyte T & B
30、cells do not get developedNormal catabolism of purines deficientBody lack messenger to identify foreign bodiesCannot initiate immune response,Science Behind SCID (2),What Caused SCID?ADA (Adenosine Deaminase) enzyme
31、deficiencyAutosomal recessive inheritance of genes coding for ADA (25%)Cannot Make T cellsSpontaneous Mutation of IL-7 Gene,Science Behind SCID (3),,Science Behind SCID (4),,Possible Therapies,Gem free tent (life long
32、)Regular injections of PEG-ADA Bone Marrow TransplantGene Therapy,GT Curing SCID (1),How mutated genes were discovered?Late 1970s – understood mechanism for immune systemMatch SCID to missing enzymeBrute force / lu
33、ck1983 – ADA cDNA identified & cloned,GT Curing SCID (2),How mutations are correctedRecombinant DNA technologies!!!Gene SplicingInsertion of correct gene into retrovirus vectorSeparate & MultiplyInsert into
34、 patient,GT Curing SCID (3),How to decide on delivery mechanism?Goals:Must take up long-term residence in patientMust be expressed adequatelyMethods:1990 – use patient’s own T cells (ADA)1993 – use blood stem cells
35、 (ADA)1999 – use blood stem cells (X-linked IL-7),GT Curing SCID (4),Gene Therapy SuccessesSo far approximately 80% success rateRestoration of normal cellular immunity in patientsBlood Stem Cells Method done on an in
36、creasing scale,SCID Cure Analysis,Why GT works in SCID?Defect at a single gene locusGenes identified & clonedUndergo irradiation or immunosuppressive chemotherapyTreatment of young children,Discussion of Ethical,
37、 Legal & Social Issues,Many issues & concerns, little answersReal life solutions come from idea brainstormsToday: Sample Medical System Framework,Current Development,Signs of DevelopmentState Law
38、s & Federal Bills which prohibits discrimination based on genetic informationSpecial committee reviewing gene therapy (NIH + FDA)3-5% of all funds for genetics studies must be used for investigation of such issues,
39、Targeted Issues,Regulation of Gene TherapyAssurance of Quality of TreatmentTargeted TreatmentDisease Treatment vs. EnhancementOnly Disease TreatmentFair & Readily Available TreatmentSame Treatment for everyone
40、At an affordable priceProtection of Genetic Information,Assumptions,Possible to isolate and provide treatment only for disease alleles without committing enhancementDevelopment in medical technologies will make medicat
41、ion cheaper in the long runModel applies for a closed country only,Model Philosophy,Possession of genetic information causes many problemsMust have a tightly regulated system in place (multi-level, multi-group)Proposa
42、lCentral Gene Therapy Monitoring Administration,Structure of Medical System,3 Levels, 5 GroupsGovernment:CGTMAReview CommitteePractitioners:DoctorsGene TherapeuticsPatients:Patients,,,,,,,,,,,Patient Treatme
43、nt Process (1),7 StepsDisease Identification1.1 Doctor Identifies Genetic ProblemApplication for Treatment2.1 Doctor Submit ApplicationTreatment Approval3.1 CGTMA Reviews Application,Patient Treatment Process (2)
44、,Preparation of Delivery Material4.1 Gene Therapeutics cure the disease genes, deliver to patient’s stem cellConfirmation of Appropriate Changes5.1 CGTMA confirms for appropriate changesGene Therapy6.1 Doctor con
45、ducts Gene Therapy to Patient,Patient Treatment Process (3),Checkup7.1 Confirm patients received only approved treatment (by CGTMA),Groups Responsibility (1),CGTMACheck validity of genetic treatment (i.e. only targeti
46、ng disease genes)Check for appropriate preparation of genetic material for gene therapyMonitor Treatment by DoctorReview CommitteeDetermine disease genes vs. enhancement genes,Groups Responsibility (2),DoctorsIdenti
47、fying DiseaseSubmitting Application for Gene TherapyConducting Gene TherapyGene TherapeuticsManipulate genes based on applicationBoth group faces penalty for illegal practices,Important Factors,Must have good inter
48、nal and external monitoring by each groupMust be aware and implement policy for patient’s privacy rightsEducation of the general public,Discussion + Q&A,How model answers targeted issuesFlaws with the modelsDiscu
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
評論
0/150
提交評論